U.S. markets closed
  • S&P 500

    4,207.27
    -2.97 (-0.07%)
     
  • Dow 30

    33,336.67
    +27.16 (+0.08%)
     
  • Nasdaq

    12,779.91
    -74.89 (-0.58%)
     
  • Russell 2000

    1,975.26
    +6.01 (+0.31%)
     
  • Crude Oil

    93.99
    +2.06 (+2.24%)
     
  • Gold

    1,805.50
    -8.20 (-0.45%)
     
  • Silver

    20.26
    -0.48 (-2.30%)
     
  • EUR/USD

    1.0324
    +0.0022 (+0.22%)
     
  • 10-Yr Bond

    2.8880
    +0.1020 (+3.66%)
     
  • GBP/USD

    1.2202
    -0.0017 (-0.14%)
     
  • USD/JPY

    132.9600
    +0.0870 (+0.07%)
     
  • BTC-USD

    24,183.38
    +359.33 (+1.51%)
     
  • CMC Crypto 200

    573.13
    -1.61 (-0.28%)
     
  • FTSE 100

    7,465.91
    -41.20 (-0.55%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Genital Herpes Treatment Market to Reach $2.9 Billion by 2027. Acyclovir Segment to Witness High Incremental Growth of $62.96 million - Arizton

·4 min read
SIRIUS MANAGEMENT CONSULTING
SIRIUS MANAGEMENT CONSULTING

The global genital herpes treatment market was valued at around $2.3 billion in 2021 and is expected to reach $2.9 billion by 2027.

Chicago, July 15, 2022 (GLOBE NEWSWIRE) -- According to Arizton’s latest research report, the global genital herpes treatment market is expected to grow at a CAGR of about 3.76%. Around one-third of MSM did not have an STI test between 2018 and 2020, while MSM with several sexual partners said they were screened less frequently in a cross-sectional survey in the US during the same period. Less monitoring and screening for STIs among MSM also increase the risk of genital herpes spread as it can be asymptomatic or have mild unrecognized symptoms. Therefore, the rise in the prevalence of genital herpes cases among the LGBTQ+ community will boost the demand for genital herpes treatment during the forecast period.

Global Genital Herpes Treatment Market Report Scope

Report Attributes

Details

MARKET SIZE (2027)

$2.3 Billion

MARKET SIZE (2021)

$2.9 Billion

CAGR (2022-2027)

3.76%

 

BASE YEAR

2021

 

FORECAST YEAR

2022-2027

MARKET SEGMENTS

Drug Type, Distribution Channel, Virus Type Route of Administration, and Region

GEOGRAPHIC ANALYSIS

North America, Europe, APAC, Latin America, and Middle East & Africa

COUNTRIES COVERED

GlaxoSmithKline, Glenmark pharmaceuticals, Viatris, Novartis, Teva Pharmaceuticals, and Bausch Health Companies

Click Here to Download the Free Sample Report

Increasing Demand for Topical Genital Herpes Treatment Drugs

The acceptance of local/topical medicines is high due to their advantages. The skin is ideal for drug administration. Medical institutions and naturopaths more frequently use local or topical drug online delivery systems. This will provide an effective and comfortable medical future to patients. Many other genital herpes drugs are available in the topical form that are also approved as OTC drugs. Patients can directly purchase such medications from drug stores or online pharmacies.

The high market penetration of genital herpes treatments in emerging economies will positively impact the overall global market and significantly contribute to its growth during the forecast period. Favorable government initiatives, an increase in healthcare expenditure, and awareness of the availability of a wide range of genital herpes treatments for various patient groups will boost the growth of the genital herpes treatment market in emerging economies during the forecast period.

Snippets

  • In 2021, North America was the major revenue contributor and accounted for 33.15% in the global genital herpes treatment market in 2021 during the forecast period.

  • The US genital herpes treatment market was estimated to be worth $834.02 million in 2027, with North America accounting for most of the market with a 90.12% share.

  • Acyclovir is the major contributor in the global genital herpes treatment market, and it is likely to witness high incremental growth of $62.96 million during the forecast period.

  • Many leading companies having a wide formulations of genital herpes drugs have been acquired by the major vendors to strengthen their market value and emerge as top player in the genital herpes treatment market.

The genital herpes treatment market is highly competitive and fragmented even though the leading companies constantly consolidate their positions through strategic and high-profile M&As. Major vendors acquire leading companies with formulations of genital herpes treatment drugs to strengthen their value and emerge as top players. These vendors implement their R&D strategies to diversify their portfolios and expand their global presence. Novartis, GSK, Glenmark Pharmaceuticals, Viatris, Teva Pharmaceuticals, and Bausch Health are key players in the global genital herpes treatment market. These key vendors add significant value to the market with their high R&D investments, diversified portfolios, and major strategic acquisitions.

Key Vendors

  • GlaxoSmithKline

  • Glenmark pharmaceuticals

  • Viatris

  • Novartis

  • Teva Pharmaceuticals

  • Bausch Health Companies

Other Prominent Vendors

  • Reddy's Laboratories

  • Cipla

  • Pfizer

  • Eli Lilly & Company

  • Avet Pharmaceuticals

  • Aurobindo Pharma

  • Centurion Remedies

  • Abbott

  • Macleods Pharmaceuticals

  • FDC

  • Hetero

  • Zydus Group

  • Torrent Pharma

  • Finecure Pharmaceuticals

  • ADLEY FORMULATIONS

  • Medico Remedies

  • Zeelab Pharmacy

Market Segmentation
Drug Type

  • Acyclovir

  • Valacyclovir

  • Famciclovir

  • Other Drugs

Distribution Channel

  • Retail Pharmacies

  • Hospital Pharmacies

  • Online Pharmacies

Virus Type

  • HSV-2

  • HSV-1

Route of Administration:

  • Oral

  • Topical

  • Injection

Region

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

  • APAC

    • China

    • Japan

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Turkey

    • Saudi Arabia

Explore our  healthcare lifesciences profile to know more about the industry.

Click Here to Download the Free Sample Report

Read some of the top-selling reports:

About Arizton: 

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals, and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Click Here to Contact Us 
Call: +1-312-235-2040 
          +1 302 469 0707

CONTACT: Arizton Advisory and Intelligence Call: +1-312-235-2040            +1 302 469 0707